CAS: 1195-45-5; 4-Fluorophenylisocyanate

该化合物是一种氟化芳烃异氰酸盐,用作有机合成的多用途中间体,其反应性异氰酸盐组得以有效地融入尿素,碳酸盐和其他衍生物,使其在药品,农用化学品和特殊材料中具有价值.氟化替代物会增强电解脱色特性,影响目标化合物的回流性和稳定性.该化合物表现出高度纯度和一贯性,适合在热循环化学和聚合物化学中精确应用.由于对水的敏感性和潜在刺激性,适当的处理是必不可少的.建议在惰性条件下储存以稳定性.

结构式图片

相似化合物

83594-83-6 59025-55-7 16744-98-2

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号32315-10-9 三光气 | CAS号371-40-4 4-氟苯胺 | CAS号456-07-5 Benzamide,4-flu... | CAS号16664-09-8 4-fluorobenzoyl... | CAS号75-44-5 光气 | CAS号33407-00-0 4-fluoro-N-trim... | CAS号456-22-4 对氟苯甲酸 | CAS号90172-63-7 Methanone, (4-f... | CAS号503-38-8 氯甲酸三氯甲酯 | CAS号352-34-1 4-氟碘苯 | CAS号29209-07-2 N-(4-Fluorophen... | CAS号13909-17-6 Urea,N-(2-chlor... | CAS号15851-81-7 Methanimidamide... | CAS号332-33-2 ,1-二甲基-3-(4-氟苯基)脲 | CAS号330-98-3 1-(4-fluorophen... | CAS号3381-48-4 N-(4-甲氧基亚苄基)-4-氟苯胺 | CAS号331983-26-7 3-(4-fluorophen... | CAS号13908-32-2 Urea,N-(2-chlor... | CAS号125766-41-8 6-(4-fluorophen... | CAS号125766-42-9 2-(1,3-benzodio...

合成工艺路线路线简述

    对氟苯甲酸置于羟胺,N,N-二异丙基乙胺,对硝基苯磺酰氯体系中,用 四氢呋喃,水,乙腈 用作溶剂,化学反应 17.0H,反应生成异氰酸对氟苯基酯
    参考文献:N-甲基咪唑催化异羟肟酸通过洛森重排合成氨基甲酸酯
    标题:N-甲基咪唑催化异羟肟酸通过洛森重排合成氨基甲酸酯
    摘要:报道了一种有效的,一锅法,N-甲基咪唑 (Nmi) 通过 Lossen 重排加速合成芳香族和脂肪族氨基甲酸酯的方法.Nmi 是将异氰酸酯中间体转化为氨基甲酸酯的催化剂.此外,芳基磺酰氯与 Nmi 组合的效用最大限度地减少了在序列过程中经常观测到的异羟肟酸酯-异氰酸酯二聚体的形成.在目前的条件下,降低温度也是可能的,从而实现温和的协议.
    Doi:10.1021/ol303424B

    海关参考信息

    专利信息


    专利号:US-8710261-B2
    优先权日:2005-02-22
    标 题:5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
    发明人:PALLE VENKATA P; SATTIGERI VISWAJANANI JITENDRA; KHERA MANOJ KUMAR; VOLETI SREEDHARA RAO; RAY ABHIJIT; DASTIDAR SUNANDA G
    权利人:PALLE VENKATA P; SATTIGERI VISWAJANANI JITENDRA; KHERA MANOJ KUMAR; VOLETI SREEDHARA RAO; RAY ABHIJIT; DASTIDAR SUNANDA G; RANBAXY LAB LTD
    摘要:The present invention relates to Compounds having the structure of Formula I: wherein n is an integer from 1 to 5; R 1 is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, aralkyl, alkoxy, aryloxy, alkenyloxy or alkynyloxy; R 2 is alkenyl, allcynyl, aryl, heterocyclyl, heteroaryl, cycloalkyl, NR 4 R 5 , —NHC(â•?Y)R 4 , —NHC(â•?Y)NR 5 R χ , —NHC(â•?O)OR 4 , —NHSO 2 R 4 , C(â•?Y)NR 4 R 5 , C(â•?O)OR 6 [wherein Y is oxygen or sulphur], OR 5 , —O(Câ•?O)NR 4 R 5 , O-acyl, S(O) m R 4 , —SO 2 N(R 4 ) 2 , cyano, amidino or guanidino [wherein R 4 is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, aralkyl, heteroarylalkyl, heterocyclylalkyl or cycloalkylalkyl and m is an integer 0-2; R 5 is hydrogen or R 4 ; R x is R 4 or —SO 2 N(R 4 ) 2 and R 6 is hydrogen, alkyl, cycloalkyl, aralkyl, heteroarylalkyl, heterocyclylalkyl or cycloalkylalkyl]; R 3 is hydrogen, fluorine, alkyl, cycloalkylalkyl or aralkyl; A is OH, OR 4 , —OC(â•?O)NR 4 R 5 , O-acyl, NH 2 , NR 4 R 5 , —NHC(â•?Y)R 4 , —NHC(â•?Y)NR 5 R x , —NHC(â•?O)OR 4 , —NHSO 2 R 4 , and to processes for the synthesis of the same. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterize by over-expression and over-activation of an matrix metalloproteinase, using the compounds.

    专利号:US-2008300251-A1
    优先权日:2005-09-05
    标 题 :Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
    发明人:SATTIGERI JITENDRA A; ANDAPPAN MURUGAIAH M S; KISHORE KAUSHAL; SETHI SACHIN; KANDALKAR SACHIN RAMESH; PAL CHANCHAL KUMAR; MAHAJAN DIPAK C; AHMED SHAHADAT; PARKALE SANTHOSH SADASHIV; SRINIVASAN T; SHARMA LALIMA; BANSAL VINAY S; CHUGH ANITA; DAVIS JOSEPH ALEXANAND
    权利人:SATTIGERI JITENDRA A; ANDAPPAN MURUGAIAH M S; KISHORE KAUSHAL; SETHI SACHIN; KANDALKAR SACHIN RAMESH; PAL CHANCHAL KUMAR; MAHAJAN DIPAK C; AHMED SHAHADAT; PARKALE SANTHOSH SADASHIV; SRINIVASAN T; SHARMA LALIMA; BANSAL VINAY S; CHUGH ANITA; DAVIS JOSEPH ALEXANAND
    摘要:The present invention relates to novel 3-azabicyclo[3.1.0]hexane derivatives as dipeptidyl peptidase-IV inhibitors and the processes for the synthesis of the said compounds. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating diabetes, especially type 2 diabetes, as well as prediabetes, diabetic dyslipidemia, metabolic acidosis, ketosis, satiety disorders, and obesity. These inhibitors can also be used to treat conditions manifested by a variety of metabolic, neurological, anti-inflammatory, and autoimmune disorders like inflammatory disease, multiple sclerosis, rheumatoid arthritis; viral, cancer and gastrointestinal disorders. The compounds of this invention can also be used for treatment of infertility arising due to polycystic ovary syndrome.

    专利号:US-4341898-A
    优先权日:1981-05-18
    标题:Synthesis of isocyanates from nitroalkanes
    发明人:MILLIGAN BARTON; PINSCHMIDT JR ROBERT K
    权利人:AIR PROD & CHEM
    摘要:A process for the preparation of aromatic isocyanates from nitroalkanes. A nitromethyl aromatic compound of the general formula: wherein R and R1 represent hydrogen, halogen, a C1-C5 alkyl radical, a C1-C4 alkoxy radical, nitro, isocyanato, an alkoxycarbonylamino, or nitromethyl radical, with R and R1 being the same or different, is heated in the presence of an effective amount of a Lewis acid or Bronsted acid substance to effect a dehydrogenation-isomerization reaction to yield an aromatic isocyanate of the general formula: The product of the reaction may be recovered as the aromatic isocyanate or the alcohol adduct, a carbamate.

    专利号:WO-9700244-A1
    优先权日:1995-06-19
    标题 :Process for parallel synthesis of a non-peptide library
    发明人:FRITZ JAMES E; KALDOR STEPHEN W
    权利人:LILLY CO ELI; FRITZ JAMES E; KALDOR STEPHEN W
    摘要:A process for the sequential preparation of a library of compounds having pharmaceutical usage. The process involves the sequential mixing of solution phase reagents, followed by scavenging of excess unreacted reagents with solid phase scavenging agents. The process is highly iterative and applicable for producing various ureas, thiureas, amides, carbonates and tertiary amines.

    专利号:US-9676783-B2
    优先权日:2008-10-22
    标 题:Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
    发明人:HAAS JULIA; ANDREWS STEVEN W; JIANG YUTONG; ZHANG GAN
    权利人:ARRAY BIOPHARMA INC
    摘要:Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

    专利号:US-2022281888-A1
    优先权日:2019-09-25
    标题:Bicyclic carboxylates as modulators of transporters and uses thereof
    发明人:SANDANAYAKA VINCENT; GORECZNY GREGORY
    权利人:NIROGY THERAPEUTICS INC
    摘要:The present invention generally relates to the field of transporter modulators, e.g., monocarboxylate transporter inhibitors, and more particularly to new bicyclic enone carboxylate compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with monocarboxylate transporter activity such as in treating cancer and other neoplastic disorders, tissue and organ transplant rejection.
    科邦特化工(杭州)有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.capot.cn
    企业联系电话:0571-85586718👤
    📞科邦特化工(杭州)有限公司 ⚠️参考联系方式
    联系人:景先生
    电话:0571-85586718
    手机:13336094967(外贸专线);13336195806(内需专线)
    传真:0571-85864795
    邮箱:sales@capot.com
    通信地址: 浙江省杭州市滨江区江陵路88号万轮科技园
    邮编: 310051
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市滨江区江陵路88号万轮科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京偶合科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ouhechem.com
    企业联系电话:010-51280831(不占线);010-82967028👤
    📞北京偶合科技有限公司 ⚠️参考联系方式
    联系人:刘先生
    电话:010-51280831(不占线);010-82967028
    手机:13911808554
    传真:010-82967029
    邮箱:sales@ouhechem.com
    通信地址: 北京市海淀区西三旗桥东上奥世纪2b-1328室
    邮编: 100096
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三旗桥东上奥世纪2b-1328室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海威远精细氟科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shwychem.com
    企业联系电话:021-64251386 64253204👤
    📞上海威远精细氟科技发展有限公司 ⚠️参考联系方式

    电话:021-64251386 64253204

    传真:021-64253354
    邮箱:wdchen@shwychem.com
    通信地址: 上海梅陇路130号华东理工科技大楼
    邮编: 200237
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海梅陇路130号华东理工科技大楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Mérour, J.-Y.; Joseph, B., Science of Synthesis Knowledge Updates, (2016) 3, 135.
    摘要:Braverman, S.; Cherkinsky, M., Science of Synthesis Knowledge Updates, (2014) 3, 305.
    摘要:Podlech, J., Science of Synthesis Knowledge Updates, (2018) 4, 169.
    摘要:Podlech, J., Science of Synthesis Knowledge Updates, (2019) 1, 397.
    摘要:Braverman, S.; Cherkinsky, M., Science of Synthesis Knowledge Updates, (2014) 3, 263.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知